Vorinostat Recruiting Phase 1 Trials for Tumors, Central Nervous System Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03050450Study of Lenalidomide With Vorinostat in Pediatric Patients With High Grade or Progressive CNS Tumors